United States Department of Health and Human Services

CMRignite Appoints Trish Taylor as Chief Strategy Officer

Retrieved on: 
Wednesday, June 28, 2023
Centers for Disease Control and Prevention, Patent, United States Department of Housing and Urban Development, Professional, AMCP, Marketing, Human services, United States Department of Health and Human Services, Platinum, National Heart, Lung, and Blood Institute, Lung, Doctor of Philosophy, Public sector, Housing, BIPOC, Weber Shandwick, D.C, Management

WASHINGTON, June 28, 2023 /PRNewswire/ -- CMRignite, the nation's largest minority-owned cause marketing and social impact agency, announced today that Trish Taylor, PhD has been named its chief strategy officer. This new hire will add expertise to the agency's behavior change portfolio, which has seen exponential growth over the past three years across its public sector clients.

Key Points: 
  • WASHINGTON, June 28, 2023 /PRNewswire/ -- CMRignite, the nation's largest minority-owned cause marketing and social impact agency, announced today that Trish Taylor, PhD has been named its chief strategy officer.
  • Taylor, who holds a doctorate in social and health psychology, is an award-winning communications professional who has led and implemented nationally recognized behavior change campaigns in the public, private and nonprofit sectors.
  • "Trish is a respected behavior change expert, as well as a passionate leader with a proven track record of spearheading large-scale integrated communications campaigns," said David Bowles, president of CMRignite.
  • In her role, Taylor will serve on the executive leadership team and lead business development and strategy across all client engagements.

Guilt-Free Peanut Pleasures

Retrieved on: 
Tuesday, June 27, 2023
Wolk, Blood pressure, Pinterest, Consumer, Mineral, PMID, Nutrition, Depression, Lethargy, Food industry, Human services, Magnesium, Chocolate, United States Department of Health and Human Services, Stroke, Ice cream, Cohort (statistics), Vitamin E, Human, PubMed Central, International Journal of Obesity, Cheese, Research, Journal of Neurology, Neurosurgery, and Psychiatry, Inflammation, Meta-analysis, Dementia, Multimedia, Vitamin, Crave, Niacin, Metabolic syndrome, Canadian International Council, Risk, Randomized controlled trial, Immune system, Johan van Scheepen, Coffee, PubMed, Journal of Internal Medicine, Magic: The Gathering core sets, 1993–2007, United States Department of Agriculture, RDA, Memory, Alzheimer's disease, Skin, Fast food, Dietary supplement, Vegetable oil, Flour, Obesity

ALBANY, Ga. , June 27, 2023 /PRNewswire/ -- A summer indulgence that's guilt-free and packed with nutrition is possible. It all starts with a base of peanut butter or peanuts since just one serving of this mighty superfood delivers protein, fiber, healthy fats and 19 vitamins and minerals.

Key Points: 
  • In a food processor, blend together a 24-ounce container of full-fat cottage cheese, ½ cup peanut butter and ¼ cup plus two tablespoons maple syrup until smooth.
  • Stir in four chopped peanut butter cups and three tablespoons chopped peanuts.
  • Based in Albany, Ga., The Peanut Institute is a non-profit organization supporting nutrition research and developing educational programs to encourage healthful lifestyles that include peanuts and peanut products.
  • Consumption of peanut products improves memory and stress response in healthy adults from the ARISTOTLE study: A 6-month randomized controlled trial.

ATCC Announces New Award from BARDA to Further Support its Medical Countermeasures Clinical Studies Network

Retrieved on: 
Tuesday, June 27, 2023
Other Health, Research, Pharmaceutical, Oncology, Infectious Diseases, Clinical Trials, Science, Biotechnology, Stem Cells, FDA, Other Science, Health, United States Department of Health and Human Services, ASPR, Biomedical Advanced Research and Development Authority, Office of Inspector General, U.S. Department of Health and Human Services, Senior, HHS, Doctor of Philosophy, CSN, Human services, Public, Trial of the century, Administration for Strategic Preparedness and Response, Government, Administration, Development, Biological specimen, Collection, BARDA, Air tasking order, Safety, Medical device, Pharmaceutical industry, ATCC

As part of this award, ATCC, a member of BARDA’s Clinical Studies Network (CSN), operates the CSN’s Biological Specimen and Investigational Product (BSIP) storage facility and provides centralized services, storage and distribution of its clinical samples and investigational products across BARDA-supported studies.

Key Points: 
  • As part of this award, ATCC, a member of BARDA’s Clinical Studies Network (CSN), operates the CSN’s Biological Specimen and Investigational Product (BSIP) storage facility and provides centralized services, storage and distribution of its clinical samples and investigational products across BARDA-supported studies.
  • “Since 2020, ATCC has been a partner in BARDA’s Clinical Study Network using demonstrated best practices for the safe and secure management of biological specimens,” said Raymond H. Cypess, D.V.M., Ph.D., chairman and CEO of ATCC.
  • “This award is another example of our ongoing support for medical countermeasures development to protect public health and safety.”
    This task order is specific to storing biosafety level 3 (BSL-3) select agents and non-select agent materials for BARDA under the Biological Specimen and Investigational Product (BSIP) program.
  • “We look forward to continuing to build our relationship with BARDA through this task order,” said Joseph Leonelli, Ph.D., Senior Vice President, and General Manager of ATCC Federal Solutions.

Webinar to Address Impact of Race on Opioid Crisis

Retrieved on: 
Monday, June 26, 2023
National Institute on Drug Abuse, Drug, Drug Enforcement Administration, Osteopathic medicine in the United States, Partnership, New Jersey Division of Consumer Affairs, Addiction, Human services, United States Department of Health and Human Services, COVID-19, Consumer protection, New Jersey Department of Health, Heller School for Social Policy and Management, Drug overdose, Heroin, Rowan-Virtua School of Osteopathic Medicine, Social policy, Opioid, Rowan University, School, Culture, New Jersey State Police, Social work, Fentanyl, True Tales of Slaughter and Slaying, Medicine, Pharmaceutical industry

The webinar, “The Intersection of Race, Culture and the Opioid Crisis,” will be held at 11 a.m. Thursday, June 29.

Key Points: 
  • The webinar, “The Intersection of Race, Culture and the Opioid Crisis,” will be held at 11 a.m. Thursday, June 29.
  • The webinar will update and expand upon information provided in previous webinars on December 9, 2021, and June 16, 2022.
  • The webinar will be the sixth in the 2023 Knock Out Opioid Abuse Day Learning Series.
  • This webinar will be the third in recent years to focus on the opioid epidemic within the context of race.

Agile Therapeutics Commends the Biden Administration’s Commitment to Strengthening Access to Affordable, High-Quality Contraception and Family Planning Services

Retrieved on: 
Friday, June 23, 2023
Cost sharing, Executive, HHS, Executive Order 13997, Birth, Health, Woman, Social policy of the Joe Biden administration, DOL, Treasury, Affordable Care Act, Patient, Ministry of Labour, Care Act 2014, Therapy, Food, United States Department of Health and Human Services, Birth control, Policy

PRINCETON, N.J., June 23, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today praised the Executive Order issued by President Biden that addresses barriers in access to high quality contraceptive care and family planning services.

Key Points: 
  • PRINCETON, N.J., June 23, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today praised the Executive Order issued by President Biden that addresses barriers in access to high quality contraceptive care and family planning services.
  • Agile Therapeutics supports the broad approach the administration is taking by directing the agencies to consider numerous other actions to improve access to contraception and family planning services across multiple dimensions.
  • We commend the Biden Administration for recognizing the importance for all women to have control over their family planning decisions without barriers.
  • We look forward to swift action by the agencies to address these challenges.” said Kimberly Whelan, Agile Therapeutics Vice President, Policy, Advocacy and Market Access.

US Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices votes to recommend AREXVY for the prevention of RSV disease in adults aged 60 and older with shared clinical decision making

Retrieved on: 
Thursday, June 22, 2023
Research, Infectious Diseases, FDA, Seniors, Biotechnology, Health, Consumer, Pharmaceutical, Science, ACIP, GSK, The New England Journal of Medicine, US Foods, Respiratory syncytial virus vaccine, Diabetes, Vaccination, United States Department of Health and Human Services, Season, Chronic lung disease, DSM-IV codes, Multimedia, Morbidity and Mortality Weekly Report, CDC, Death, GSK plc, RSV, State, Patient, Risk, MMWR, Stockholm Environment Institute US Center, Kidney, Ageing, Disease, III, Food, Vaccine, Poultry farming

GSK plc (LSE/NYSE: GSK) today announced that the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted in favor of recommending the use of AREXVY (respiratory syncytial virus vaccine, adjuvanted) in adults aged 60 and older using shared clinical decision making.

Key Points: 
  • GSK plc (LSE/NYSE: GSK) today announced that the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted in favor of recommending the use of AREXVY (respiratory syncytial virus vaccine, adjuvanted) in adults aged 60 and older using shared clinical decision making.
  • Shared clinical decision making empowers patients in consultation with their healthcare providers to determine whether RSV vaccination is appropriate for them.
  • These data will be submitted to the US Food and Drug Administration (FDA) for review.
  • The ACIP recommendations will be forwarded to the director of the CDC and the US Department of Health and Human Services for review and approval.

Upcoming Webinar Spotlights Prostate Cancer and Black Men

Retrieved on: 
Wednesday, June 21, 2023
Seele, Prostate cancer, Education, Human services, United States Department of Health and Human Services, Health status of Asian Americans, Multimedia, CDC, National Cancer Institute, AL, TLC, MD, Balm, Balm in Gilead (book), Diagnosis, Urology, Death, Disease, Birth control, Mobile phone, Janssen, Black

RICHMOND, Va., June 21, 2023 /PRNewswire/ -- Due to stark health disparities in the United States that result in higher rates of prostate cancer diagnosis and death for Black men, The Balm In Gilead, Inc., a national non-profit organization, will present a free webinar titled "Talk That Talk: Prostate Cancer and Black Men" on June 27, 2023 at 7:00pmET via Zoom at https://bit.ly/43rArw3. Registration is required.

Key Points: 
  • RICHMOND, Va., June 21, 2023 /PRNewswire/ -- Due to stark health disparities in the United States that result in higher rates of prostate cancer diagnosis and death for Black men, The Balm In Gilead, Inc., a national non-profit organization, will present a free webinar titled "Talk That Talk: Prostate Cancer and Black Men" on June 27, 2023 at 7:00pmET via Zoom at https://bit.ly/43rArw3 .
  • "Because one in six Black men will be diagnosed with prostate cancer, our webinar will address gaps that contribute to delays in Black men seeking screening and treatment for this disease," said Pernessa C. Seele, Ph.D., founder and CEO of The Balm In Gilead, Inc. "We need to ''talk that talk" within our families, congregations, and communities.
  • "Talk That Talk: Prostate Cancer and Black Men" will address how families and faith communities can help build awareness about prostate cancer.
  • Prostate cancer hits Black men harder than their white counterparts.

Fentanyl Crisis Alert: FentanylSolution.org Sheds Light on the Alarming Impact of Fentanyl on Senior Citizens

Retrieved on: 
Tuesday, June 20, 2023
Pharmacy, Human services, Health, Fentanyl, Woman, Attention, Drug overdose, Los Angeles Times, Heroin, CDC, Death, Morphine, Baja, Prescription drug addiction, Risk, Pain management, Ageing, United States Department of Health and Human Services, Addiction, Drug

With a mission to educate and protect senior citizens, FentanylSolution.org is raising awareness about the devastating consequences of fentanyl abuse within this vulnerable population.

Key Points: 
  • With a mission to educate and protect senior citizens, FentanylSolution.org is raising awareness about the devastating consequences of fentanyl abuse within this vulnerable population.
  • The fentanyl crisis is making it worse, the perfect storm.
  • Senior citizens are increasingly falling victim to the grip of illicit fentanyl, a potent synthetic opioid that poses a significant risk.
  • Unfortunately, many of the brick-and-mortar pharmacies along the Baja Peninsula are distributing pharmaceuticals that have tested positive for fentanyl.

Sorrento Therapeutics, Inc. announces a $4.6 Million U.S. Government contract from the NIAID for a Sensitive, Reusable, and Rapid Diagnostic Platform for Pandemic Preparedness

Retrieved on: 
Tuesday, June 13, 2023
Doctor of Philosophy, McAfee VirusScan, Human services, Infection, National Institute of Allergy and Infectious Diseases, United States Department of Health and Human Services, Unitary state, Federal, Antibody, National Institutes of Health, Government, Bangladesh Technical Education Board, Alcopop, Chemistry, Protein, SAN, OTC, Controversies regarding COVID-19 contracts in the United Kingdom, Therapy, NIH, Vaccine

The purpose of the contract is to develop a diagnostic platform for rapid and sensitive detection of proteins and other biomolecules that improves existing rapid testing devices (RTDs).

Key Points: 
  • The purpose of the contract is to develop a diagnostic platform for rapid and sensitive detection of proteins and other biomolecules that improves existing rapid testing devices (RTDs).
  • Current diagnostic RTDs have long development timelines and low clinical sensitivity.
  • Sorrento and Virex Health, LLC (Virex Health), a wholly owned subsidiary of Sorrento, plan to develop an adaptable diagnostic platform which is highly sensitive and cost-effective for multiple pathogens.
  • The objective is to address the needs of rapid detection for biodefense and new emerging infectious disease preparedness.

GovCIO Wins Corporate Growth Award at 21st Annual ACG National Capital Awards Gala

Retrieved on: 
Tuesday, June 13, 2023
United States Agency for International Development, Drug, SDVOSB, Welsh, Carson, Anderson & Stowe, Veterans' affairs, United States Environmental Protection Agency, United States Department of Veterans Affairs, United States Postal Service, Association for Corporate Growth, Human services, Health, Intelligence, National Capital Planning Commission, Salient CRGT, International development, Government, 2022 Rogers Communications outage, Stowe, Salient, Acquisition, Philippine Drug Enforcement Agency, CFO, Growth, Commodity Futures Trading Commission, Capital city, Mail, ACG, Contract management, United States Department of Health and Human Services, Cryptocurrency, Defense, Homeland security, Research

FAIRFAX, Va., June 13, 2023 /PRNewswire/ -- GovCIO won the Association for Corporate Growth (ACG) National Capital's Corporate Growth Company Award in the over $250 million category presented June 8 at the 21st Annual ACG Corporate Growth Awards Gala.

Key Points: 
  • FAIRFAX, Va., June 13, 2023 /PRNewswire/ -- GovCIO won the Association for Corporate Growth (ACG) National Capital's Corporate Growth Company Award in the over $250 million category presented June 8 at the 21st Annual ACG Corporate Growth Awards Gala.
  • ACG's National Capital chapter honored GovCIO with this award following its significant growth in 2022 and the company's contributions to making the National Capital region one of the best in which to do business.
  • Key achievements leading to this win included 25% annual organic revenue growth to over $840 million, over $1.3 billion in contract wins, 2.2x book to bill since August 2021, and the company's successful rebrand to GovCIO.
  • "We are honored to have won this prestigious award," said Jim Brabston, GovCIO CEO.